Skip to main content
Log in

Low In Vitro Production of Interferon-γ and Tumor Necrosis Factor-α in HIV-Seronegative Patients with Pulmonary Disease Caused by Nontuberculous Mycobacteria

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

We studied 32 HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria (NTM). Immunologic studies included lymphocyte subset analysis by flow cytometry, measurement of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) production followingin vitro stimulation of diluted whole blood (DWB) and peripheral blood mononuclear cells (PBMC) by phytohemagglutinin (PHA), anti-CD3 as well as purified protein derivative of tuberculin (PPD), and in four cases with different amounts of the very mycobacterium, which caused disease in these patients. Data were compared to those of 30 HIV-seronegative patients with disease byMycobacterium tuberculosis (MTb). Following α-CD3-stimulation of PBMC, NTM patients showed lower IFN-γ(P < 0.00005) and lower TNF-α(P < 0.02). For a subgroup of tuberculin skin test-positive NTM patients we found significantly lower PPD-induced IFN-γ releases in cultured DWB(P < 0.0002) and PBMC(P < 0.0004) compared to MTb patients. Data for PPD-induced TNF-α release for this subgroup were also significant(P < 0.001 andP < 0.05, respectively). The four NTM patients with poor PPD-induced IFN-γ response hardly showed increased cytokine production on stimulation with their specific mycobacterium. The lower production capacity of IFN-γ and TNF-α of NTM patients compared to the MTb patients points to an immunologic imbalance forming the basis for their increased susceptibility to pulmonary infections by nontuberculous mycobacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107-159, 1979

    Google Scholar 

  2. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE: Infection with Mycobacterium avium complex in patients without predisposing conditions [see comments]. N Engl J Med 321:863-868, 1989

    Google Scholar 

  3. Reich JM, Johnson RE: Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis 143:1381-1385, 1991

    Google Scholar 

  4. Rosenzweig DY: Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases. Chest 75:115-119, 1979

    Google Scholar 

  5. Etzkorn ET, Aldarondo S, McAllister KC, Matthels J, Ognebene AJ: Medical therapy of Mycobacterium avium-intracellulare pulmonary disease. Am Rev Respir Dis 134:442-445, 1986

    Google Scholar 

  6. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670-689, 1983

    Google Scholar 

  7. Schluger NW, Rom WN: The host immune response to tuberculosis. Am J Respir Crit Care Med 157:679-691, 1998

    Google Scholar 

  8. Onwubalili JK, Scott GM, Robinson JA: Deficient immune interferon production in tuberculosis. Clin Exp Immunol 59:405-413, 1985

    Google Scholar 

  9. Taha RA, Kotsimbos TC, Song YL, Menzies D, Hamid Q: IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 155:1135-1139, 1997

    Google Scholar 

  10. Sodhi A, Gong J, Silva C, Qian D, Barnes PF: Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis 25:617-620, 1997

    Google Scholar 

  11. Levin M, Newport MJ, D'Souza S, Kalabalikis P, Brown IN, Lenicker HM, Agius PV, Davies EG, Thrasher A, Klein N, Blackwell JM: Familial disseminated atypical mycobacterial infection in childhood: A human mycobacterial susceptibility gene? [see comments]. Lancet 345:79-83, 1995

    Google Scholar 

  12. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova JL: Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335:1956-1961, 1996

    Google Scholar 

  13. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M: A mutation in the interferon-gammareceptor gene and susceptibility to mycobacterial infection. N Engl J Med 335:1941-1949, 1996

    Google Scholar 

  14. Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, Gallin JI: Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 330:1348-1355, 1994

    Google Scholar 

  15. Chatte G, Panteix G, Perrin-Fayolle M, Pacheo Y: Aerolized interferon gamma for Mycobacterium avium-complex lung disease. Am J Respir Crit Care Med 152:1094-1096, 1995

    Google Scholar 

  16. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassali P: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740, 1989

    Google Scholar 

  17. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S: IL4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by TH1 and TH2 cell clones. J Immunol 149:2977-2983, 1992

    Google Scholar 

  18. American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156:S1-25, 1997

    Google Scholar 

  19. Hartman T, Swensen SJ, Williams DE: Mycobacterium avium-intracellulare complex: Evaluation with CT. Radiology 187:23-26, 1993

    Google Scholar 

  20. Kimura M, Converse PJ, Atemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NMH, Chaisson R, Bishai WR: Comparison between a whole blood interferon gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. J Infect Dis 179:1297-1300, 1999

    Google Scholar 

  21. von Reyn CF, Williams DE, Horsburgh Jr. CR, Jaeger AS, Marsh BJ, Haslov K, Magnusson M: Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 177:730-736, 1998

    Google Scholar 

  22. Kabelitz D: Do CD2 and CD3-TCR T-cell activation pathways function independently? Immunol Today 11(2):44-47, 1990

    Google Scholar 

  23. Abb J, Abb H, Deinhardt F: Age-related decline of human interferon alpha and interferon gamma production. Blut 48:285-289, 1984

    Google Scholar 

  24. Vilcek J, Klion A, Henriksen-DeStefano D, Zemtsov A, Davidson DM, Davidson M, Friedman-Kien AE, Le J: Defective gammainterferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 6:146-151, 1986

    Google Scholar 

  25. Mason III UG, Greenberg LE, Yen SS, Kirkpatrick CH: Indomethacin-responsive mononuclear cell dysfunction in “atypical” mycobacteriosis. Cell Immunol 71:54-65, 1982

    Google Scholar 

  26. Froebel KS, Bollert FG, Jellema J, Bird AG, Greening AP: Immunodeficiency in nontuberculous mycobacterial disease. Respir Med 91:95-101, 1997

    Google Scholar 

  27. Huang J, Oefner PJ, Adi V, Ratnam K, Ruoss SJ, Trako E, and Kao PN: Analysis of the NRAMP1 and IFN-gamma R1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med 157(2):377-381, 1998

    Google Scholar 

  28. Condos R, Rom W, Schluger N: Treatment of multi-drug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 349:1513-1515, 1997

    Google Scholar 

  29. Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing CD4 T cells. J Exp Med 178:1655-1663, 1993

    Google Scholar 

  30. Giosuè S, Casarini M, Alemanno L, Gallucio G, Mattai P, Pedicelli G, Rebek L, Bisetti A, Ameglio F: Effects of aerolized interferonalpha in patients with pulmonary tuberculosis. Am J Resp Crit Care Med 158:1156-1162, 1998

    Google Scholar 

  31. Bermudez LE, Young LS: Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140:3006-3013, 1988

    Google Scholar 

  32. Ottenhoff TMH, Kumararatne D, Casanova J-L: Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunology Today 10:491-494, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greinert, U., Schlaak, M., Rũsch-Gerdes, S. et al. Low In Vitro Production of Interferon-γ and Tumor Necrosis Factor-α in HIV-Seronegative Patients with Pulmonary Disease Caused by Nontuberculous Mycobacteria. J Clin Immunol 20, 445–452 (2000). https://doi.org/10.1023/A:1026407815946

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026407815946

Navigation